OMERS Administration Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.81M Buy
30,100
+21,628
+255% +$7.11M 0.06% 156
2025
Q4
$2.97M Hold
8,472
0.02% 289
2025
Q3
$2.74M Sell
8,472
-100
-1% -$31.1K 0.02% 311
2025
Q2
$3.33M Sell
8,572
-179,661
-95% -$72.3M 0.03% 227
2025
Q1
$81.9M Sell
188,233
-122,191
-39% -$49.1M 0.72% 43
2024
Q4
$115M Buy
310,424
+1,581
+0.5% +$662K 1% 32
2024
Q3
$161M Sell
308,843
-71,042
-19% -$38M 1.48% 22
2024
Q2
$206M Sell
379,885
-12,157
-3% -$6.43M 1.98% 11
2024
Q1
$203M Hold
392,042
2.33% 12
2023
Q4
$185M Buy
392,042
+304,545
+348% +$141M 2.33% 13
2023
Q3
$38.1M Hold
87,497
0.57% 44
2023
Q2
$38.9M Buy
87,497
+10,000
+13% +$4.61M 0.6% 46
2023
Q1
$35.6M Buy
77,497
+42,100
+119% +$20M 0.55% 47
2022
Q4
$18.2M Hold
35,397
0.29% 53
2022
Q3
$16.1M Hold
35,397
0.27% 55
2022
Q2
$17.1M Hold
35,397
0.25% 59
2022
Q1
$17.4M Hold
35,397
0.22% 60
2021
Q4
$16.4M Hold
35,397
0.21% 63
2021
Q3
$13.2M Buy
+35,397
New +$13.5M 0.19% 58
2021
Q2
Sell
-28,571
Closed -$10.3M 37
2021
Q1
$10.3M Hold
28,571
0.16% 60
2020
Q4
$9.17M Sell
28,571
-98,861
-78% -$30.3M 0.17% 65
2020
Q3
$34.2M Hold
127,432
0.72% 38
2020
Q2
$33.5M Sell
127,432
-80,037
-39% -$21.4M 1.11% 32
2020
Q1
$47.1M Sell
207,469
-97,623
-32% -$26.6M 2.11% 16
2019
Q4
$92.1M Sell
305,092
-255,000
-46% -$70.2M 1.06% 35
2019
Q3
$134M Hold
560,092
1.34% 23
2019
Q2
$160M Buy
560,092
+15,193
+3% +$4.15M 1.67% 20
2019
Q1
$162M Sell
544,899
-104,880
-16% -$30.3M 1.86% 23
2018
Q4
$171M Sell
649,779
-37,276
-5% -$10.2M 2.24% 14
2018
Q3
$188M Sell
687,055
-11,592
-2% -$3.01M 1.8% 17
2018
Q2
$166M Sell
698,647
-29,700
-4% -$6.88M 1.54% 23
2018
Q1
$160M Buy
728,347
+3,200
+0.4% +$752K 1.56% 20
2017
Q4
$163M Sell
725,147
-46,253
-6% -$9.85M 1.63% 20
2017
Q3
$146M Buy
771,400
+49,430
+7% +$9.41M 1.62% 22
2017
Q2
$136M Sell
721,970
-26,200
-4% -$4.71M 1.72% 19
2017
Q1
$124M Buy
748,170
+70,360
+10% +$11.2M 1.65% 17
2016
Q4
$97.4M Sell
677,810
-159,540
-19% -$21.4M 1.81% 16
2016
Q3
$105M Buy
837,350
+344,050
+70% +$44.4M 1.87% 13
2016
Q2
$64.8M Buy
493,300
+35,400
+8% +$4.84M 1.33% 21
2016
Q1
$63.6M Buy
457,900
+36,500
+9% +$4.88M 1.41% 26
2015
Q4
$58.8M Buy
421,400
+412,000
+4,383% +$56.8M 1.52% 20
2015
Q3
$1.32M Buy
+9,400
New +$1.41M 0.04% 223

Other funds holding ELV

OMERS Administration Corp's ELV Position: Q1 2026 in Review

OMERS Administration Corp increased its Elevance Health (ELV) stake by 255% in Q1 2026, buying an estimated $7.11M and bringing the position to 30,100 shares worth $8.81M. The position accounts for 0.06% of the portfolio, ranked #156.

OMERS Administration Corp first reported a position in ELV in Q3 2015 and has held it in 42 quarters since. The position peaked at $206M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • OMERS Administration Corp held 30,100 shares of Elevance Health worth $8.81M as of Q1 2026.
  • OMERS Administration Corp bought 21,628 Elevance Health shares in Q1 2026, an estimated $7.11M.
  • Elevance Health made up 0.06% of OMERS Administration Corp's portfolio in Q1 2026, its #156 holding.
  • OMERS Administration Corp first reported a position in Elevance Health in Q3 2015 and has held it in 42 quarters since.
  • OMERS Administration Corp's Elevance Health position peaked at $206M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.